TGA reveals second blood clotting event linked to AstraZeneca vaccine
The patient in her 40s remains in hospital and is in a stable condition
A second Australian case of thrombosis with thrombocytopenia has been linked to AstraZeneca’s COVID-19 vaccine.
It occurred in a woman in her 40s who was vaccinated in WA.
It is not clear whether the vaccination was administered in a GP practice or through one of the state’s vaccination clinics.
Last night, the TGA’s Vaccine Safety Investigation Group — made up of expert advisors including infectious disease physicians and haemotologists — reviewed the case in detail and concluded it was similar to those seen in Europe and the UK.
